MyoKardia Performance
The company secures a Beta (Market Risk) of 0.0, which conveys not very significant fluctuations relative to the market. the returns on MARKET and MyoKardia are completely uncorrelated.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days MyoKardia has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent basic indicators, MyoKardia is not utilizing all of its potentials. The current stock price mess, may contribute to short-term losses for the institutional investors. ...more
| Quick Ratio | 17.74 | |
| Fifty Two Week Low | 42.65 | |
| Target High Price | 225.00 | |
| Fifty Two Week High | 225.00 | |
| Target Low Price | 225.00 |
MyoKardia |
MyoKardia Relative Risk vs. Return Landscape
If you would invest (100.00) in MyoKardia on January 24, 2024 and sell it today you would earn a total of 100.00 from holding MyoKardia or generate -100.0% return on investment over 90 days. MyoKardia is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than MyoKardia, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
MyoKardia Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for MyoKardia's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as MyoKardia, and traders can use it to determine the average amount a MyoKardia's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| MYOK |
Based on monthly moving average MyoKardia is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of MyoKardia by adding MyoKardia to a well-diversified portfolio.
MyoKardia Fundamentals Growth
MyoKardia Stock prices reflect investors' perceptions of the future prospects and financial health of MyoKardia, and MyoKardia fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on MyoKardia Stock performance.
| Return On Equity | -42.7 | |||
| Return On Asset | -23.07 | |||
| Current Valuation | 11.15 B | |||
| Shares Outstanding | 53.32 M | |||
| Price To Earning | (57.57) X | |||
| Price To Book | 14.19 X | |||
| Price To Sales | 253.61 X | |||
| Revenue | 12.4 M | |||
| EBITDA | (280.21 M) | |||
| Cash And Equivalents | 895.88 M | |||
| Cash Per Share | 16.80 X | |||
| Total Debt | 51.61 M | |||
| Debt To Equity | 0.06 % | |||
| Book Value Per Share | 15.85 X | |||
| Cash Flow From Operations | (195.1 M) | |||
| Earnings Per Share | (5.66) X | |||
| Total Asset | 81.36 M | |||
| Retained Earnings | (491.37 M) | |||
| Current Asset | 77.88 M | |||
| Current Liabilities | 12.21 M |
Things to note about MyoKardia performance evaluation
Checking the ongoing alerts about MyoKardia for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for MyoKardia help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| MyoKardia is not yet fully synchronised with the market data | |
| MyoKardia has some characteristics of a very speculative penny stock | |
| MyoKardia has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 12.4 M. Net Loss for the year was (276.96 M) with loss before overhead, payroll, taxes, and interest of (226.17 M). | |
| MyoKardia currently holds about 895.88 M in cash with (195.1 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 16.8. | |
| Over 95.0% of the company shares are owned by institutional investors |
- Analyzing MyoKardia's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether MyoKardia's stock is overvalued or undervalued compared to its peers.
- Examining MyoKardia's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating MyoKardia's management team can have a significant impact on its success or failure. Reviewing the track record and experience of MyoKardia's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of MyoKardia's stock. These opinions can provide insight into MyoKardia's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in MyoKardia Stock
If you are still planning to invest in MyoKardia check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MyoKardia's history and understand the potential risks before investing.
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |